17Jan
15Jan
University of Minnesota Twin Cities and Windgap Medical receive $3.2 million NIH grant to develop cyanide antidote autoinjector
The University of Minnesota Twin Cities and Windgap Medical have received a $3.2 million grant from the National Institutes of Health (NIH) to develop a new device to quickly administer a recently developed antidote for cyanide poisoning. Under the grant, researchers from the University’s Center for Drug Design, College of Pharmacy, and Massachusetts-based pharmaceutical company Windgap Medical are collaborating to design an autoinjector. Read more >>
15Jan
Cognoptix developing an Alzheimer’s disease test using the eye
Cognoptix Inc CEO Susanne Wilke sat down with Proactive's Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Concord, Massachusetts-based company develops non-invasive eye tests for the early diagnosis of Alzheimer's disease. Read more >>
14Jan
Venture firm that invests in SC reports record year, pumping $12.7 million into Southeast startups
One of the few venture funds making investments in South Carolina reported another record year in 2019, scaling up its capital outlays by 82 percent from 2018. VentureSouth, which is based in Greenville and has local chapters, focuses on promising companies in the Southeast, including Zylo Therapeutics. Read more >> "
11Jan
Tech companies tackle safety issues with new devices
Safety for babies, bike riders, and curious kids are all on display at CES 2020 - Suffice it to say, there’s a lot -- a LOT -- of stuff at the Consumer Electronics Show. The product Landsdowne created to offset the dangers of ingesting a battery is called “ChildLok.” The company claims that, through deactivation, chemical burns, permanent tissue damage to the esophagus, and even death may be reduced. Read more >>
08Jan
3Derm announces two FDA Breakthrough Device designations for autonomous skin cancer AI
3Derm Systems, Inc. (3Derm), a leader in the skin imaging and diagnostics industry, announced today that it has been granted two FDA Breakthrough Device designations for 3DermSpot, an algorithm that uses artificial intelligence (AI) and highly standardized skin images to autonomously detect melanoma, squamous cell carcinoma, and basal cell carcinoma. Read more >>
04Jan
Aircuity joins Real-Time Energy Management scheme in New York
Aircuity has announced that it has been named a New York State Energy Research and Development Authority (NYSERDA) Qualified Vendor for the Real-Time Energy Management (RTEM) programme. The NYSERDA offers a 30% cost-share incentive for building owners to deploy energy management solutions such as Aircuity’s platform. Read more >>
25Dec
OpenText Buys Carbonite, Inc.
OpenText™ announced today that it has completed the closing of the previously announced acquisition of Carbonite, Inc., provider of cloud-based subscription data protection, backup, disaster recovery and endpoint security to small and medium-sized businesses and prosumers. Read more >> "
21Dec
Raider magic: Blind man given sight through digital glasses
“I can see you! I can see you all!” Michael Clinton shouted as he pointed around the gymnasium — guided by his new eSight glasses — at the cheering Raider students and faculty Friday morning. Clinton, 66, was diagnosed with degenerative disease that over time caused him to lose his vision, and with it, his ability to hold a job or drive. Read more >>
20Dec